Refine search

Date
Tumour Site
Topics
Congress

32 results for ""

More needs to be done in renal cancer

More needs to be done in renal cancer

Up to 90% of patients will die from metastatic disease and the search for biomarkers lags behind other tumour types, says ESMO Lifetime Achievement Award 2022 winner Prof. Bernard Escudier  

Lesley Seymour receives the TAT Honorary Award 2022

Lesley Seymour receives the TAT Honorary Award 2022

In her keynote lecture at the ESMO Targeted Anticancer Therapies Congress 2022, Prof. Lesley Seymour stresses the importance of sharing ideas and resources between academia and industry 

Quality cancer care starts with training oncologists at the highest standards

Quality cancer care starts with training oncologists at the highest standards

Despite the encouraging findings of a new global survey demonstrating a high rate of uptake of the ESMO/ASCO Global Curriculum in Medical Oncology, resource limitations in lower-income regions as well as country-specific political circumstances may be hindering its implementation locally.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.